Corrigendum to: "A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease" [Eur Urol 2009;56:363-70] (DOI:10.1016/j.eururo.2009.05.012);A First Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Evaluating Extracorporeal Shock Wave Therapy for the Treatment of Peyronie's Disease

European Urology

Volumn 56, Issue 2, 2009, Pages 363-370

  Palmieri, Alessandro ^a   Imbimbo, Ciro ^a   Longo, Nicola ^a   Fusco, Ferdinando ^a   Verze, Paolo ^a   Mangiapia, Francesco ^a   Creta, Massimiliano ^a   Mirone, Vincenzo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Double blind placebo controlled study; Extracorporeal shock wave therapy; Peyronie's disease

Indexed keywords

PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXTRACORPOREAL LITHOTRIPSY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PEYRONIE DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; VISUAL ANALOG SCALE;

EID: 67649441067     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2009.07.039     Document Type: Erratum

References (28)

1. Bivalacqua T.J., Purohit S.K., and Hellstrom W.J. Peyronie's disease: advances in basic science and pathophysiology. Curr Urol Rep 1 (2000) 297-301
2. Bekos A., Arvaniti M., Hatzimouratidis K., Moysidis K., Tzortzis V., and Hatzichristou D. The natural history of Peyronie's disease: an ultrasonography-based study. Eur Urol 53 (2008) 644-651
3. Mirone V., Imbimbo C., Palmieri A., Longo N., Fusco F., and Tajana G. A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy. Eur Urol 42 (2002) 239-244
4. Hamm R., McLarty E., Ashdown J., Natale S., and Dickinson A. Peyronie's disease-the Plymouth experience of extracorporeal shockwave treatment. BJU Int 87 (2001) 849-852
5. Gelbard M.K., Dorey F., and James K. The natural history of Peyronie's disease. J Urol 144 (1990) 1376-1379
6. Hauck E.W., Diemer T., Schmelz H.U., and Weidner W. A critical analysis of nonsurgical treatment of Peyronie's disease. Eur Urol 49 (2006) 987-997
7. Williams J.L., and Thomas G.G. The natural history of Peyronie's disease. J Urol 103 (1970) 75-76
8. Mulhall J.P., Schiff J., and Guhring P. An analysis of the natural history of Peyronie's disease. J Urol 175 (2006) 2115-2118
9. Butz M., and Teichert H.M. Treatment of Peyronie's disease (PD) by extracorporeal shock waves (ESW). J Urol 159 Suppl 5 (1998) 118
10. Hauck E.W., Hauptmann A., Bschleipfer T., Schmelz H.U., Altinkilic B.M., and Weidner W. Questionable efficacy of extracorporeal shock wave therapy for Peyronie's disease: results of a prospective approach. J Urol 171 (2004) 296-299
11. Hauck E.W., Mueller U.O., Bschleipfer T., Schmelz H.U., Diemer T., and Weidner W. Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of clinical trials. J Urol 171 (2004) 740-745
12. Rosen R.C., Cappelleri J.C., Smith M.D., Lipsky J., and Peña B.M. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11 (1999) 319-326
13. Haag S.M., Hauck E.W., Szardening-Kirchner C., et al. Alterations in the transforming growth factor (TGF)-β pathway as a potential factor in the pathogenesis of Peyronie's disease. Eur Urol 51 (2007) 255-261
14. Lucattelli M., Lunghi B., Fineschi S., et al. A new mouse model of Peyronie's disease: an increased expression of hypoxia-inducible factor-1 target genes during the development of penile changes. Int J Biochem Cell Biol 40 (2008) 2638-2648
15. Lebret T., Hervé J.M., Lugagne P.M., et al. Extra-corporeal lithotripsy in the treatment of Peyronie's disease. Use of a standard lithotriptor (Multiline Siemens) on "young" (less than 6 months old) plaques. Prog Urol 10 (2000) 65-70
16. Pryor J.P., and Ralph D.J. Clinical presentations of Peyronie's disease. Int J Impot Res 14 (2002) 414-417
17. Hauck E.W., Altinkilic B.M., Ludwig M., et al. Extracorporal shock wave therapy in the treatment of Peyronie's disease: first results of a case-controlled approach. Eur Urol 38 (2000) 663-670
18. Kiyota H., Ohishi Y., Asano K., et al. Extracorporeal shock wave treatment for Peyronie's disease using EDAP LT-02; preliminary results. Int J Urol 9 (2002) 110-113
19. Poulakis V., Skriapas K., de Vries R., et al. Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?. Asian J Androl 8 (2006) 361-366
20. Lingeman J.E., McAteer J.A., Kempson S.A., and Evan A.P. Bioeffects of extracorporeal shock wave lithotripsy: strategy for research and treatment. Urol Clin North Am 15 (1988) 507-514
21. El-Sakka A.I. Prevalence of Peyronie's disease among patients with erectile dysfunction. Eur Urol 49 (2006) 564-569
22. Rosen R., Catania J., Lue T., et al. Impact of Peyronie's disease on sexual and psychosocial functioning: qualitative findings in patients and controls. J Sex Med 5 (2008) 1977-1984
23. Lebret T., Loison G., Hervé J.M., et al. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotriptor (Siemens-multiline). Urology 59 (2002) 657-661
24. Skolarikos A., Alargof E., Rigas A., Deliveliotis C., and Konstantinidis E. Shockwave therapy as first-line treatment for Peyronie's disease: a prospective study. J Endourol 19 (2005) 11-14
25. Claro J.A., Passerotti C.C., Figueiredo Neto A.C., Nardozza Jr. A., Ortiz V., and Srougi M. An alternative non-invasive treatment for Peyronie's disease. Int Braz J Urol 30 (2004) 199-204
26. Wild C., Khene M., and Wanke S. Extracorporeal shock wave therapy in orthopedics. Assessment of an emerging health technology. Int J Technol Assess Health Care 16 (2000) 199-209
27. Mirone V., Imbimbo C., Palmieri A., and Fusco F. Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica. Eur Urol 36 (1999) 327-330
28. Husain J., Lynn N.N., Jones D.K., Collins G.N., and O'Reilly P.H. Extracorporeal shock wave therapy in the management of Peyronie's disease: initial experience. BJU Int 86 (2000) 466-468